Hosted on MSN11mon
GSK expands Asia-Pacific reach for Trelegy Ellipta with Singapore approval
Singapore’s Health Sciences Authority (HSA) has expanded the label of GlaxoSmithKline (GSK)’s Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) to ...
Taiwan News3d
Report: RSV-associated Hospitalisation Costs in Singapore Estimated at SGD 9,430 per Patient; Poses Financial Strain on At-risk Older Adults
Amongst the APEC countries and regions in the survey, hospitalisation costs per older adult in Singapore amounted to SGD ...
Nature3y
Jingwu Zang
Senior Vice President, Head of R&D China, GlaxoSmithKline ... we now have about 210 staff in Shanghai and about 50 staff in Singapore. Approximately 45% of the staff have been recruited from ...